Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse (English)
- New search for: Montefusco, Vittorio
- New search for: Corso, Alessandro
- New search for: Galli, Monica
- New search for: Ardoino, Ilaria
- New search for: Pezzatti, Sara
- New search for: Carniti, Cristina
- New search for: Patriarca, Francesca
- New search for: Gherlinzoni, Filippo
- New search for: Zambello, Renato
- New search for: Sammassimo, Simona
- New search for: Marcatti, Magda
- New search for: Nozza, Andrea
- New search for: Crippa, Claudia
- New search for: Cafro, Anna Maria
- New search for: Baldini, Luca
- New search for: Corradini, Paolo
- New search for: Montefusco, Vittorio
- New search for: Corso, Alessandro
- New search for: Galli, Monica
- New search for: Ardoino, Ilaria
- New search for: Pezzatti, Sara
- New search for: Carniti, Cristina
- New search for: Patriarca, Francesca
- New search for: Gherlinzoni, Filippo
- New search for: Zambello, Renato
- New search for: Sammassimo, Simona
- New search for: Marcatti, Magda
- New search for: Nozza, Andrea
- New search for: Crippa, Claudia
- New search for: Cafro, Anna Maria
- New search for: Baldini, Luca
- New search for: Corradini, Paolo
In:
British Journal of Haematology
;
188
, 6
;
907-917
;
2020
- Article (Journal) / Electronic Resource
-
Title:Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse
-
Contributors:Montefusco, Vittorio ( author ) / Corso, Alessandro ( author ) / Galli, Monica ( author ) / Ardoino, Ilaria ( author ) / Pezzatti, Sara ( author ) / Carniti, Cristina ( author ) / Patriarca, Francesca ( author ) / Gherlinzoni, Filippo ( author ) / Zambello, Renato ( author ) / Sammassimo, Simona ( author )
-
Published in:British Journal of Haematology ; 188, 6 ; 907-917
-
Publisher:
-
Publication date:2020-03-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 188, Issue 6
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 805
-
Issue Information| 2020
- 812
-
Eosinophils engulfing platelets and with ring‐shaped nuclei in nivolumab‐associated eosinophiliaDelgado‐Serrano, Javier / Morales‐Camacho, Rosario M. / Caballero‐Velázquez, Teresa / García‐Canale, Silvia / Vargas, M. Teresa / Prats‐Martín, Concepción et al. | 2020
- 813
-
An immunotherapy‐induced plasma cell leukaemoid reactionMassari, Evita / Rosetti, Marco / Poletti, Giovanni / Ronconi, Sonia / Dorizzi, Romolo M. et al. | 2020
- 814
-
Guidelines for iron deficiency in pregnancy: hope aboundsAuerbach, Michael / Georgieff, Michael K. et al. | 2020
- 817
-
Mutant allelic burden in acute myeloid leukaemia: Why bother?Touw, Ivo P. / Sanders, Mathijs A. et al. | 2020
- 819
-
UK guidelines on the management of iron deficiency in pregnancyPavord, Sue / Daru, Jan / Prasannan, Nita / Robinson, Susan / Stanworth, Simon / Girling, Joanna / on behalf of the BSH Committee et al. | 2020
- 831
-
What do we know about duodenal‐type follicular lymphoma? From pathological definition to treatment optionsDuffles Amarante, Guilherme / Collins, Graham / Rocha, Vanderson et al. | 2020
- 838
-
Annotation: travel and thrombosisCzuprynska, Julia / Arya, Roopen et al. | 2020
- 844
-
Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemiaGribben, John G. et al. | 2020
- 852
-
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemiaLinch, David C. / Hills, Robert K. / Burnett, Alan K. / Russell, Nigel / Gale, Rosemary E. et al. | 2020
- 860
-
Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOPJeon, Young‐Woo / O, Joo‐Hyun / Park, Kyung‐Sin / Min, Gi June / Park, Sung‐Soo / Yoon, Jae‐Ho / Eom, Ki‐Seong / Min, Chang‐Ki / Cho, Seok‐Goo et al. | 2020
- 872
-
Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLLElston, Lauren / Fegan, Chris / Hills, Robert / Hashimdeen, Shaikh S. / Walsby, Elisabeth / Henley, Peter / Pepper, Chris / Man, Stephen et al. | 2020
- 881
-
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemiaHoltzman, Noa G. / El Chaer, Firas / Baer, Maria R. / Ali, Omer / Patel, Ameet / Duong, Vu H. / Sausville, Edward A. / Singh, Zeba N. / Koka, Rima / Zou, Ying S. et al. | 2020
- 888
-
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: Spanish Lymphoma Group Experience (GELTAMO)Bento, Leyre / Díaz‐López, Antonio / Barranco, Gilberto / Martín‐Moreno, Ana M. / Baile, Mónica / Martín, Alejandro / Sancho, Juan M. / García, Olga / Rodríguez, Mario / Sánchez‐Pina, Jose M. et al. | 2020
- 898
-
First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4Walewski, Jan / Paszkiewicz‐Kozik, Ewa / Michalski, Wojciech / Rymkiewicz, Grzegorz / Szpila, Tomasz / Butrym, Aleksandra / Giza, Agnieszka / Zaucha, Jan M. / Kalinka‐Warzocha, Ewa / Wieczorkiewicz, Agata et al. | 2020
- 907
-
Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapseMontefusco, Vittorio / Corso, Alessandro / Galli, Monica / Ardoino, Ilaria / Pezzatti, Sara / Carniti, Cristina / Patriarca, Francesca / Gherlinzoni, Filippo / Zambello, Renato / Sammassimo, Simona et al. | 2020
- 918
-
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemiaEyre, Toby A. / Roeker, Lindsey E. / Fox, Christopher P. / Gohill, Satyen H. / Walewska, Renata / Walter, Harriet S. / Forconi, Francesco / Broom, Angus / Arumainathan, Arvind / Brander, Danielle M. et al. | 2020
- 924
-
Extended experience with a non‐cytotoxic DNMT1‐targeting regimen of decitabine to treat myeloid malignanciesAwada, Hassan / Mahfouz, Reda Z. / Kishtagari, Ashwin / Kuzmanovic, Teodora / Durrani, Jibran / Kerr, Cassandra M. / Patel, Bhumika J. / Visconte, Valeria / Radivoyevitch, Tomas / Lichtin, Alan et al. | 2020
- 930
-
Impact of imaging modality on clinical outcome in Hodgkin lymphoma in a resource constraint settingKorula, Anu / Devasia, Anup Joseph / Kulkarni, Uday / Abubacker, Fouzia N. / Lakshmi, Kavitha M. / Abraham, Aby / Srivastava, Alok / George, Biju / Mathews, Vikram et al. | 2020
- 935
-
Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progressionCottin, Laurane / Riou, Jérémie / Orvain, Corentin / Ianotto, Jean Christophe / Boyer, Françoise / Renard, Maxime / Truchan‐Graczyk, Matgorzata / Murati, Anne / Jouanneau‐Courville, Rébecca / Allangba, Olivier et al. | 2020
- 945
-
Changes in neurocognitive function and central nervous system structure in childhood acute lymphoblastic leukaemia survivors after treatment: a meta‐analysisZhou, Chendan / Zhuang, Yong / Lin, Xingjie / Michelson, Alan D. / Zhang, Aijun et al. | 2020
- 962
-
A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post‐thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)Bradbury, Charlotte / Fletcher, Kate / Sun, Yongzhong / Heneghan, Carl / Gardiner, Chris / Roalfe, Andrea / Hardy, Pollyanna / McCahon, Debbie / Heritage, Gail / Shackleford, Helen et al. | 2020
- 976
-
Paediatric haematologists’ attitudes regarding haematopoietic cell transplantation as treatment for sickle cell diseaseStallings, Alicia M. / Majhail, Navneet S. / Nowacki, Amy S. / Onimoe, Grace I. / Hanna, Rabi / Piccone, Connie M. et al. | 2020
- 985
-
5‐(Hydroxymethyl)furfural restores low‐oxygen rheology of sickle trait blood in vitroHansen, Scott / Wood, David K. / Higgins, John M. et al. | 2020
- e80
-
Haemolytic anaemia: an unrecognised side effect of hydroxyurea?Cornelisse, Alex C. / Bergkamp, Ferry J. M. / Griffioen‐Keijzer, Anita et al. | 2020
- e82
-
Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumabUzunov, Madalina / Demeret, Sophie / Nguyen‐Quoc, Stéphanie / Morel, Véronique / Bellanger, Agnès / Chavez, Houria / Gasnault, Jacques / Leblond, Véronique / Roos‐Weil, Damien et al. | 2020
- e84
-
Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLHNaik, Swati / Eckstein, Olive / Sasa, Ghadir / Heslop, Helen E. / Krance, Robert A. / Allen, Carl / Martinez, Caridad et al. | 2020
- e87
-
Bernard–Soulier syndrome: first human case due to a homozygous deletion of GP9 geneGhalloussi, Dorsaf / Rousset‐Rouvière, Caroline / Popovici, Cornel / Garaix, Florentine / Saut, Noémie / Saultier, Paul / Tsimaratos, Michel / Chambost, Hervé / Alessi, Marie‐Christine / Baccini, Véronique et al. | 2020
- e90
-
Dysregulation of miRNA expression and their prognostic significance in paediatric cytogenetically normal acute myeloid leukaemiaGaur, Vikas / Chaudhary, Shilpi / Tyagi, Anudishi / Agarwal, Suyash / Sharawat, Surender K. / Sarkar, Siddik / Singh, Harpreet / Bakhshi, Sameer / Sharma, Pankaj / Kumar, Sachin et al. | 2020
- e94
-
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphomaLee, Hun J. / Schmelz, Jacob L. / Cramer, Fred / Romaguera, Jorge E. / Badillo, Maria / Wang, Michael et al. | 2020
- e98
-
Erythroblastic sarcoma with rare PDGFRA rearrangement responding to tyrosine kinase inhibitor therapyTomlinson, Benjamin / Raess, Philipp W. / Beck, Rose C. / Moore, Erika M. et al. | 2020
- e101
-
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemiaGiona, Fiorina / Malaspina, Francesco / Putti, Maria Caterina / Ladogana, Saverio / Mura, Rosamaria / Burnelli, Roberta / Vacca, Nadia / Rizzo, Lorenzo / Bianchi, Simona / Moleti, Maria Luisa et al. | 2020
- e105
-
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UKHarrison, Claire N. / Mead, Adam J. / Drummond, Mark W. / Chiu, Gavin / Bains, Rozinder et al. | 2020
- e109
-
The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population‐based study in the Netherlandsvan der Straten, Lina / Levin, Mark‐David / Visser, Otto / Blijlevens, Nicole M.A. / Cornelissen, Jan J. / Doorduijn, Jeanette K. / Kater, Arnon P. / Dinmohamed, Avinash G. et al. | 2020